Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000349
Status:
UNKNOWN
Last Update Posted:
2017-01-11
First Post:
1999-09-20
Brief Title:
Infusion Laboratory Protocol 5 Flupenthixol - 14
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Infusion Laboratory Protocol 5 Flupenthixol
Status:
UNKNOWN
Status Verified Date:
2002-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol to cocaine and to their interaction and to determine how pretreatment with flupenthixol modifies the subjective as well as physiological effects of cocaine Taken together these relatively D-1 selective agents can help determine the extent to which DA-1 binding affects the reinforcing effects of stimulants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Y01-3-0010-14 | None | None | None |